602 related articles for article (PubMed ID: 16634167)
21. What to do about scientific misconduct.
Nature; 1994 May; 369(6478):261-2. PubMed ID: 8183349
[No Abstract] [Full Text] [Related]
22. Salem comes to the National Institutes of Health: notes from inside the crucible of scientific integrity.
Needleman HL
Pediatrics; 1992 Dec; 90(6):977-81. PubMed ID: 1331947
[No Abstract] [Full Text] [Related]
23. Scientific misconduct: undue process.
Efron R
Account Res; 1993; 3(2-3):223-38. PubMed ID: 11652297
[No Abstract] [Full Text] [Related]
24. Regulating human gene therapy.
Areen J
West VA Law Rev; 1985; 88(2):153-71. PubMed ID: 11655150
[No Abstract] [Full Text] [Related]
25. Data audit by a regulatory agency: its effect and implication for others.
Shapiro MF
Account Res; 1992; 2(3):219-29. PubMed ID: 11653981
[No Abstract] [Full Text] [Related]
26. Which ethics for science and public policy?
Irving DN; Shamoo AE
Account Res; 1993; 3(2-3):77-100. PubMed ID: 11652298
[No Abstract] [Full Text] [Related]
27. Deception in scientific research.
Woolf PK
Jurimetrics; 1988; 29(1):67-95. PubMed ID: 11654908
[No Abstract] [Full Text] [Related]
28. Scientific misconduct. Back to the drawing board.
Anderson C
Nature; 1991 Mar; 350(6314):100. PubMed ID: 1848681
[No Abstract] [Full Text] [Related]
29. Giving scientists their due. The Imanishi-Kari decision.
Dresser R
Hastings Cent Rep; 1997; 27(3):26-8. PubMed ID: 9219021
[No Abstract] [Full Text] [Related]
30. NSF's approach to misconduct in science.
Buzzelli DE
Account Res; 1993; 3(2-3):215-21. PubMed ID: 11652296
[No Abstract] [Full Text] [Related]
31. Money is putting people at risk in biomedical research.
Andrews LB
Chron High Educ; 2000 Mar; 46(27):B1, B4-5. PubMed ID: 11657699
[No Abstract] [Full Text] [Related]
32. Safeguards questioned: some worry that policies to protect human research subjects may be inadequate.
Burd S
Chron High Educ; 1994 Feb; 40():30-1. PubMed ID: 11660767
[No Abstract] [Full Text] [Related]
33. Congressmen investigate scientific fraud.
Perspectives Prof; 1981; 1(3-4):10-2. PubMed ID: 11649375
[No Abstract] [Full Text] [Related]
34. Research misconduct and its federal regulation: the origin and history of the Office of Research Integrity--with personal views by ORI's former associate director for investigative oversight.
Price AR
Account Res; 2013; 20(5-6):291-319. PubMed ID: 24028479
[TBL] [Abstract][Full Text] [Related]
35. 'Misconduct' dispute raises fears of litigation.
Dalton R
Nature; 1997 Jan; 385(6612):105. PubMed ID: 8990102
[No Abstract] [Full Text] [Related]
36. If only it were so: medical physics, U.S. human radiation experiments, and the Final Report of the President's Advisory Committee (ACHRE).
Martensen R
Med Humanit Rev; 1997; 11(2):21-36. PubMed ID: 11645853
[No Abstract] [Full Text] [Related]
37. Conscience, regulation and scientific misconduct.
Lumley J
Res Publica; 1994; 3(1):1-3. PubMed ID: 16619463
[No Abstract] [Full Text] [Related]
38. Changing explanatory frameworks in the U.S. Government's attempt to define research misconduct.
Guston DH
Sci Eng Ethics; 1999 Apr; 5(2):137-54. PubMed ID: 11657850
[No Abstract] [Full Text] [Related]
39. The Office of Scientific Integrity investigations: the importance of data analysis.
Price AA; Hallum JV
Account Res; 1992; 2(2):133-7. PubMed ID: 16144092
[No Abstract] [Full Text] [Related]
40. Duke research resumes; policy debate widens.
Weiss R
Washington Post; 1999 May; ():A2. PubMed ID: 11647725
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
